The inhibition of prostaglandin and prostacyclin synthesis in the clinical management of patent ductus arteriosus.
D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011464:Epoprostenol / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007385:Intermittent Positive-Pressure Ventilation; D008026:Ligation; D011247:Pregnancy; D011453:Prostaglandins / Q000096:biosynthesis*
D011453:Prostaglandins; D011464:Epoprostenol; D007213:Indomethacin